您的位置:网站名称 → 研发专利新闻 → 正文
内容搜索
热门内容
推荐内容
最新内容
反馈意见和建议

USPTO issues Notice of Allowance to AlphaRx ARX8203 pain product candidate


AlphaRx Inc. (OTC BB:ALRX.OB) has received a Notice of Allowance from the United States Patent and Trademark Office for its lead pain product candidate code named ARX8203, a potentially safer drug intended for pain treatment. AlphaRx has...

查看所有的文章内容需要 VIP会员权限 查看


 
点这里复制本页地址发送给您QQ/MSN上的好友

相关文章

• VARI, Gentel Biosciences receive U.S. Pa
• Colorcon announces specific details on i
• ACT to be awarded broad patent protectio
• NephRx receives new U.S. patent for NX00
• USPTO grants patent to ULURU's Altrazeal
• NephRx receives new U.S. patent for NX00
• PRWP receives two new patents for Galect
• POZEN files motion for Treximet patent l
• BDSI's BEMA drug delivery technology rec
• USPTO grants patent to HistoRx methods f
• US District Court rules against Watson i
• U.S. District Court rules in favor of Wa
• Biotectix acquires Chameleon BioSurfaces
• USPTO issues Notice of Allowance to Modu
• USPTO issues patent to Somaxon's Silenor
• USPTO grants composition-of-matter paten
• USPTO issues patent to Asterand's BioMAP
• Medical industry veteran set to play key
• Cubist enters license agreement with Tev
• Shire files lawsuit against Watson over

相关评论


本文章所属分类:首页 → 研发专利新闻